Cargando…
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
Oct-4 and Nanog in regulating the epithelial-mesenchymal transition (EMT) and metastasis of breast cancer has not been clarified. We found that both Oct-4 and Nanog expression were significantly associated with tumor pathology and poor prognosis in 126 breast cancer patients. Characterization of CD4...
Autores principales: | Wang, Dan, Lu, Ping, Zhang, Hao, Luo, Minna, Zhang, Xin, Wei, Xiaofei, Gao, Jiyue, Zhao, Zuowei, Liu, Caigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279411/ https://www.ncbi.nlm.nih.gov/pubmed/25301732 |
Ejemplares similares
-
Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021) -
NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017) -
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
por: Paranjape, Anurag N, et al.
Publicado: (2014) -
MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2012) -
Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)